Author:
Henkel Joachim,Lüttke Robert
Reference37 articles.
1. Allarakhia M, Wensley A (2005) Innovation and intellectual property rights in systems biology. Nat Biotechnol 23(12):1485–1488. doi:
10.1038/nbt1205-1485
2. Allen AC, Timothy KL (2012) Synthetic biology: an emerging engineering discipline. Ann Rev Biomed Eng 14:155–178
3. Cohen WM, Nelson RR, Walsh JP (2000) Protecting their intellectual assets: appropriability conditions and why U.S. manufacturing firms patent (or not). Working Paper 7552 NATIONAL BUREAU OF ECONOMIC RESEARCH, Cambridge, MA 02138,
http://www.nber.org/papers/w7552
4. Dickson M, Gagnon JP (2004) Key factors in the rising cost of new drug discovery and development. Nat Rev Drug Discov 3(5):417–429. doi:
10.1038/nrd1382
5. Dimasi JA, Hansen RW, Grabowski HG (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22(2):151–185. doi:
10.1016/S0167-6296(02)00126-1
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献